Published in J Obstet Gynaecol Can on October 01, 2003
Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol Cancer Res (2008) 1.27
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration. Prostate (2011) 0.99
New insights into the regulation of human cytotrophoblast cell differentiation. Mol Cell Endocrinol (2009) 0.95
The role of activin A and Akt/GSK signaling in ovarian tumor biology. Endocrinology (2008) 0.94
Genetics of primary ovarian insufficiency: a review. J Assist Reprod Genet (2014) 0.85
Potential targets of transforming growth factor-beta1 during inhibition of oocyte maturation in zebrafish. Reprod Biol Endocrinol (2005) 0.85
Transforming growth factor-beta inhibits aromatase gene transcription in human trophoblast cells via the Smad2 signaling pathway. Reprod Biol Endocrinol (2009) 0.82
Involvement of transcription factor NR2F2 in human trophoblast differentiation. PLoS One (2010) 0.79
Growth differentiation factor 9 of Megalobrama amblycephala: molecular characterization and expression analysis during the development of early embryos and growing ovaries. Fish Physiol Biochem (2013) 0.76
Growth-differentiation factor-8 (GDF-8) in the uterus: its identification and functional significance in the golden hamster. Reprod Biol Endocrinol (2009) 0.75